shenzhen salubris pharmaceuticals co., ltd.-凯发官网首页

 shenzhen salubris pharmaceuticals co., ltd.-凯发官网首页

multiple product developed strategically in therapeutic area to treat thrombosis and coagulation

we have thecornerstone products of antiplatelet drugs, clopidogrel bisulfate tablets(taijia), ticagrelor tablets (taiyi), and bivalirudin for injection, which isthe first generic drug in china.

now we have formed the complementary advantages of taijia, taiyi  andtaijianing in the field of antithrombosis, and will continue to developinnovative drugs of small molecule anticoagulant.

existing product line

网站地图